Online citations, reference lists, and bibliographies.
← Back to Search

The Role Of Nanoparticle Size In Hemocompatibility.

A. Mayer, M. Vadon, B. Rinner, A. Novak, R. Wintersteiger, E. Fröhlich
Published 2009 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
It is expected that nanoparticular matters will be increasingly used for industrial and medical applications. Since it is known that nanoparticles exhibit unique and potential hazardous properties due to their small size, toxicity studies, risk assessment and risk management are of great interest. We focussed on adverse effects on human blood. Processes which warrant special attention are clotting, reactions triggering inflammatory and immune responses and hemolysis. Starting with the determination of size and surface charge in different media we assessed the effect of size and surface charge on induction of coagulation, thrombocyte activation, complement activation, granulocyte activation and hemolysis. We used polystyrene particles as model because they are available in different sizes but constant surface charges. The presence of salts and of protein in the dispersion solution increased particle size and neutralized surface charge. Positively charged particles formed aggregates in buffered solution. Interference of the particles with assays based on fluorescence associated cell sorting was identified. Positive surface charge induced activation of complement. Small size caused thrombocyte and granulocyte activation, and hemolysis. A characterization of particle size and surface charge in the solutions used for the experiments appears important for interpretation of the results. The size dependency of adverse effects in human blood is not linear; negatively charged particles larger than 60 nm hydrodynamic diameter appear to be considerably less hematotoxic than smaller ones.
This paper references
Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.
L. Muldoon (2006)
10.1023/B:PHAM.0000036909.41843.18
Effects of the Chemical Structure and the Surface Properties of Polymeric Biomaterials on Their Biocompatibility
Y. Wang (2004)
10.1172/JCI30639
Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway.
G. Mutlu (2007)
10.1038/nbt875
The potential environmental impact of engineered nanomaterials
V. Colvin (2003)
10.3109/9781420045154
Nanotoxicology : characterization, dosing and health effects
N. Monteiro-Riviere (2007)
10.2147/IJN.S596
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
10.1016/S1359-6446(05)03654-8
Nanomedicine transforms drug delivery.
Catherine Shaffer (2005)
10.1007/BF02970133
Pulmonary inflammation and crystalline silica in respirable coal mine dust: Dose response
E. Kuempel (2008)
10.4314/TJPR.V5I1.14634
Nanoparticles - A Review
V. Mohanraj (2007)
10.1289/ehp.7339
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
10.1007/S004200000185
Pulmonary effects of inhaled ultrafine particles
G. Oberdörster (2001)
10.1186/1477-3155-2-12
Nanoparticles – known and unknown health risks
P. Hoet (2004)
10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
Hemocompatibility of treated polystyrene substrates: contact activation, platelet adhesion, and procoagulant activity of adherent platelets.
J. Grunkemeier (1998)
10.1054/ARTH.2002.30416
Exposure to particles stimulates superoxide production by human THP-1 macrophages and avian HD-11EM osteoclasts activated by tumor necrosis factor-alpha and PMA.
M. Wang (2002)
10.1006/JCIS.1996.0338
Production of contact-free nanoparticles by aerosol process : Dependence of particle size on gas pressure
S. Tohno (1996)
10.1016/0142-9612(90)90091-4
Mechanisms of blood coagulation induced by latex particles and the roles of blood cells.
M. Miyamoto (1990)
10.1021/NL061025K
Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm.
T. Xia (2006)
10.1016/J.IJPHARM.2006.11.047
In vitro evaluation of dendrimer prodrugs for oral drug delivery.
M. Najlah (2007)
10.1073/pnas.0805135105
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
10.1089/JAM.2005.18.1
Cardiovascular effects of fine and ultrafine particles.
H. Schulz (2005)
10.1289/ehp.9688
Cardiovascular Effects of Pulmonary Exposure to Single-Wall Carbon Nanotubes
Z. Li (2007)
10.1002/MASY.200551014
Characterization and Properties of Hybrid Nanoparticle “inactive and active” Metal Polymer Films
E. Espuche (2005)
10.1002/ADMA.200602667
Length-Dependent Uptake of DNA-Wrapped Single-Walled Carbon Nanotubes
M. Becker (2007)
10.1007/s11095-005-7547-7
Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles
J. Koziara (2005)
10.1016/J.TOXLET.2004.11.006
Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration.
P. G. Barlow (2005)
10.1016/j.jinorgbio.2007.12.028
Cytotoxicity of mesoporous silica nanomaterials.
Anthony J. Di Pasqua (2008)
10.1289/ehp.9254
In Search of the Most Relevant Parameter for Quantifying Lung Inflammatory Response to Nanoparticle Exposure: Particle Number, Surface Area, or What?
K. Wittmaack (2007)
10.1289/ehp.8903
Effects of Airway Exposure to Nanoparticles on Lung Inflammation Induced by Bacterial Endotoxin in Mice
K. Inoue (2006)
10.1093/CLINCHEM/43.7.1215
Preparation of lyophilized partial thromboplastin time reagent composed of synthetic phospholipids: usefulness for monitoring heparin therapy.
A. M. van den Besselaar (1997)
10.1016/S0378-5173(02)00623-3
The influence of surface modification on the cytotoxicity of PAMAM dendrimers.
R. Jevprasesphant (2003)
10.1088/0957-4484/18/19/195102
Latex nanoparticles for multimodal imaging and detection in vivo
R. Cartier (2007)
10.1289/ehp.8497
Induction of Inflammation in Vascular Endothelial Cells by Metal Oxide Nanoparticles: Effect of Particle Composition
A. Gojova (2007)
10.1016/J.COLSURFB.2004.07.001
Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials.
S. Sagnella (2005)
10.1111/j.1538-7836.2005.01559.x
Exposure to diesel exhaust nanoparticles does not induce blood hypercoagulability in an at‐risk population
A. Blomberg (2005)
10.1016/J.ADDR.2006.09.011
Nanomedicine: developing smarter therapeutic and diagnostic modalities.
O. Farokhzad (2006)
10.1016/S0142-9612(02)00445-3
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.
D. Fischer (2003)
10.1186/1743-8977-3-11
The potential risks of nanomaterials: a review carried out for ECETOC
P. Borm (2006)
10.1002/9783527631544
Nanoparticles : from theory to application
Geunther Schmid (2010)
10.1093/TOXSCI/KFG228
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats.
D. Warheit (2004)
10.1006/TAAP.2001.9240
Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines.
D. Brown (2001)
10.1289/EHP.9087337
Evidence of an oxidative mechanism for the hemolytic activity of silica particles.
B. L. Razzaboni (1990)
10.1016/j.chemosphere.2007.11.047
Toxicity of nanosized and bulk ZnO, CuO and TiO2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus.
M. Heinlaan (2008)
10.3109/9781420045154-4
Nanotoxicology: Laying a Firm Foundation for Sustainable Nanotechnologies
A. Maynard (2007)
10.1093/OCCMED/KQL052
Nanomedicines and nanotoxicology: some physiological principles.
M. Garnett (2006)
10.1002/JBM.A.30315
Improving the blood compatibility of polyurethane using carbon nanotubes as fillers and its implications to cardiovascular surgery.
Jie Meng (2005)
10.1078/1438-4639-00200
Hemolytic activity of crystalline silica--separated erythrocytes versus whole blood.
W. Hadnagy (2003)
10.1039/B309043B
Dendrimers in drug research.
U. Boas (2004)
10.1023/A:1010012802415
Gold Nanoparticles: Production, Reshaping, and Thermal Charging
M. Magnusson (1999)
Nanoparticles and microparticles for drug and vaccine delivery.
J. Kreuter (1996)
10.1161/01.CIR.103.23.2810
Increased Particulate Air Pollution and the Triggering of Myocardial Infarction
A. Peters (2001)



This paper is referenced by
10.11575/PRISM/26195
Fluid flow effects on nanoparticle localization in zebrafish vessels and cultured human endothelial cells
Maria Juliana Gómez (2017)
10.1007/978-981-13-0481-1_4
Viral- and Non-viral-Based Hybrid Vectors for Gene Therapy
Manohar Mahato (2018)
10.1016/j.jconrel.2014.12.030
Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
A. Wicki (2015)
10.5812/SEMJ.85196
The Role of Curcumin on Reduced Leukocyte and Platelet Counts in Rats After Exposure to Ultraviolet Light from Compact Fluorescent Lamps: A Morphological Study
N. Khalaji (2019)
Aus dem Institut für Transfusionsmedizin der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION One-pot Formulation of Protein Submicron Particles and Their Haemocompatibility zur Erlangung des akademischen Grades Doctor rerum medicinalium (Dr. rer. medic.) vorgelegt der Me
(2019)
10.5772/INTECHOPEN.75750
Nanomedicines for Cutaneous Leishmaniasis
A. J. Sousa-Batista (2018)
10.1186/1556-276X-8-395
Acute and chronic nephrotoxicity of platinum nanoparticles in mice
Y. Yamagishi (2013)
Development and characterisation of antiretroviral drugs encapsulated in polymer stabilised oil-in-water nanoemulsions
James J Hobson (2015)
Elastin-like polypeptide mediated proangiogenic and anti-inflammatory gene therapy for critical limb ischemia
B. Dash (2014)
A Study on the ZnO/CuO Nano-Diode Multilayer and Some of its Physical Properties
Farhah Elfadel Omer (2018)
10.1016/j.nano.2017.07.012
Biocompatibility assessment of silk nanoparticles: hemocompatibility and internalization by human blood cells.
Manfred F. Maitz (2017)
10.1021/nn901503q
Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping.
S. George (2010)
10.3109/10408444.2010.494174
Review: Do engineered nanoparticles pose a significant threat to the aquatic environment?
T. M. Scown (2010)
10.2217/nnm.11.33
Iron core/shell nanoparticles as magnetic drug carriers: possible interactions with the vascular compartment.
I. Herrmann (2011)
10.3109/15376516.2012.757686
Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation
Xiaojia Wang (2013)
Nanoparticules d'or à couronne polymère modulable : synthèse, interactions avec les systèmes biologiques et propriétés de radiosensibilisation
Marine Le Goas (2019)
10.4028/WWW.SCIENTIFIC.NET/AMR.971-973.228
Synthesis and Hemolytic Activity of Magnesium Hydroxide Nanoparticles
W. Zhou (2014)
10.1002/jat.3437
Preclinical safety assessments of nano‐sized constructs on cardiovascular system toxicity: A case for telemetry
Hoay Yan Cheah (2017)
10.1016/j.biomaterials.2010.07.067
The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility.
B. Dash (2010)
10.1016/j.biomaterials.2012.06.056
Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy.
Vikas Jain (2012)
10.1007/978-3-319-41421-8_9
Evaluating the Interactions Between Proteins and Components of the Immune System with Polymer Nanoparticles
Silvia Lorenzo-Abalde (2016)
10.3389/fcvm.2019.00139
Effect on Platelet Function of Metal-Based Nanoparticles Developed for Medical Applications
Nadhim Hante (2019)
10.1142/9789814390262_0007
The Effects of Engineered Nanomaterials on Erythrocytes
Bridget E Wildt (2013)
10.1016/j.nano.2017.01.019
Gold nanoparticle interactions in human blood: a model evaluation.
Niloofar Ajdari (2017)
10.1002/wnan.1546
Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies.
P. Urban (2019)
10.2147/IJN.S58397
Aneuploidogenic effects and DNA oxidation induced in vitro by differently sized gold nanoparticles
Sebastiano Di Bucchianico (2014)
10.1016/j.biopha.2014.07.015
Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
R. Sankar (2014)
10.1016/J.TIFS.2016.10.013
Nanoparticles in feed: Progress and prospects in poultry research
Sheeana Gangadoo (2016)
10.1016/j.biomaterials.2013.05.077
Multifunctional calcium phosphate nano-contrast agent for combined nuclear, magnetic and near-infrared in vivo imaging.
Anusha Ashokan (2013)
eview anomaterials and the environment : A review for the biennium 2008 – 2010
ose R. Peralta-Videaa (2011)
Investigation of the effects of nanoparticle size on blood activation using a human wholeblood model
Elias Heed (2015)
ANTIMICROBIAL ACTIVITY AND HEMOCOMPATIBILITY OF CHITOSAN COATED SILK FIBROIN MICRO-FIBERS A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF APPLIED SCIENCES OF NEAR EAST UNIVERSITY By PWADUBASHIYI COSTON PWAVODI
()
See more
Semantic Scholar Logo Some data provided by SemanticScholar